Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fujian Aonong Biological Technology Grouporp Scaled Net Operating Assets Chart
Fujian Aonong Biological Technology Grouporp Annual Data
SHSE:603363 vs ADM, BG, TSN: Scaled Net Operating Assets Comparison
For the Farm Products subindustry, Fujian Aonong Biological Technology Grouporp's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fujian Aonong Biological Technology Grouporp Scaled Net Operating Assets vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Fujian Aonong Biological Technology Grouporp's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Fujian Aonong Biological Technology Grouporp's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of 0.62 mean?
Fujian Aonong Biological Technology Grouporp (SHSE:603363) has a Scaled Net Operating Assets of 0.62 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Fujian Aonong Biological Technology Grouporp and its competitors.
Is Fujian Aonong Biological Technology Grouporp's Scaled Net Operating Assets too high?
Fujian Aonong Biological Technology Grouporp's current Scaled Net Operating Assets is 0.62. Overall, Fujian Aonong Biological Technology Grouporp has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fujian Aonong Biological Technology Grouporp's Scaled Net Operating Assets compare to ADM and BG?
Fujian Aonong Biological Technology Grouporp's Scaled Net Operating Assets of 0.62 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Consumer Packaged Goods company?
A good Scaled Net Operating Assets depends on the Consumer Packaged Goods industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Fujian Aonong Biological Technology Grouporp and its competitors. Fujian Aonong Biological Technology Grouporp's current Scaled Net Operating Assets is 0.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fujian Aonong Biological Technology Grouporp stock overvalued right now?
Based on GuruFocus' analysis, Fujian Aonong Biological Technology Grouporp (SHSE:603363) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥1.32, compared to a current price of ¥2.67 — trading 102.3% above its estimated fair value. The current Scaled Net Operating Assets is 0.62. Fujian Aonong Biological Technology Grouporp's overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Fujian Aonong Biological Technology Grouporp (SHSE:603363), the current Scaled Net Operating Assets is 0.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fujian Aonong Biological Technology Grouporp (SHSE:603363) Overvalued in 2026?
Based on GuruFocus' analysis, Fujian Aonong Biological Technology Grouporp stock appears to be overvalued.
The current stock price of ¥2.67 is trading 102.3% above its estimated GF Value™ of ¥1.32.
GuruFocus considers Fujian Aonong Biological Technology Grouporp to be Significantly Overvalued.
Key valuation signals for SHSE:603363:
Scaled Net Operating Assets: 0.62
GF Value™: ¥1.32 vs. price of ¥2.67 (102.3% above fair value)
No single metric tells the full story. See the SHSE:603363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fujian Aonong Biological Technology Grouporp Business Description
Fujian Aonong Biological Technology Group Incorp Ltd is an agricultural and animal husbandry enterprise in China. The principal business activities of the company include feed-oriented service, animal protection, pig raising, and raw material trade. In addition, the company's insurance business mainly relies on the feed marketing system throughout the country to provide downstream farmers with relevant products for disease prevention and control.
31GF Score
Get the complete analysis for SHSE:603363
Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603363 has been successfully added to your 
